Skip to content
Retail trade
KZActiveBIN 100440017277
Plans from 2 000 ₸ a month
No entries in risk registers
Registers checked: 18
To risks

ТОО "ЕВРОАЗИЯФАРМ"

Director
Какишева Камила Решатовна
Incorporated
23.04.2010
Address
Восточно-Казахстанская область ул. КАБАНБАЙ БАТЫРА, 49
РНН
181600270851

This is a company preview

Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.

The pack is not a subscription, its checks last 30 days

Risks

0/18

This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.

Procurement signals

Court cases

Arrests & encumbrances

Enforcement proceedings

Certificates

Licenses and permits

Profile

Summary

Full name
ТОВАРИЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ЕВРОАЗИЯФАРМ"
BIN
100440017277
Status
Active
Director
Какишева Камила Решатовна
Registration date
23.04.2010
Activity
Розничная торговля фармацевтическими товарами в специализированных магазинах, являющихся торговыми объектами, с торговой площадью менее 2000 кв.м
Legal address
Восточно-Казахстанская область ул. КАБАНБАЙ БАТЫРА, 49

In government contracts over 2 years

  • Восточно-Казахстанская область, г.Усть-Каменогорск, имени Кабанбай Батыра, 49 matches the registered one

    contract of 28.12.2024
VAT payer
No, deregistered 23.06.2023
КАТО
631010000
РНН
181600270851
КФС
Собственность предприятий без государственного и иностранного участия
КСЕ
Национальные частные нефинансовые корпорации – ОПП
Company size
Малые предприятия
Employees
от 0 до 5 чел.

Has changed

Procurement role
Поставщик

Activities

1
47731primary

Розничная торговля фармацевтическими товарами в специализированных магазинах, являющихся торговыми объектами, с торговой площадью менее 2000 кв.м

Download

Contacts

Change history

Financials

Tax payments

6

By year · ₸

2026
185.2K
2025
17M-40%
2024
28.2M+39%
2023
20.3M+20%
2022
16.9M+674%
2021
2.2M
·185.2K
2026year to date
-40%17M
2025
+39%28.2M
2024
+20%20.3M
2023
+674%16.9M
2022
·2.2M
2021
2026
Tax paid185,168 ₸
Penalty1,050 ₸
Fine0 ₸
VAT refund0 ₸
2025
Tax paid16,967,248 ₸
Penalty1,200 ₸
Fine0 ₸
VAT refund0 ₸
2024
Tax paid28,197,648 ₸
Penalty650 ₸
Fine25,844 ₸
VAT refund0 ₸
2023
Tax paid20,251,422 ₸
Penalty350 ₸
Fine0 ₸
VAT refund0 ₸
2022
Tax paid16,895,018 ₸
Penalty2,000 ₸
Fine45,945 ₸
VAT refund0 ₸
2021
Tax paid2,182,380 ₸
Penalty0 ₸
Fine0 ₸
VAT refund0 ₸
Download

Financial statements

Premium

Public contracts

What it sells and where

Samruk-Kazyna procurement

Tender bids

Procurement as a customer

Assets

Bank accounts

Management & owners

Leadership

2
  • КК

    Какишева Камила Решатовна

    Director

Former directors

  • МГМЕЙРЕНБАЕВА ГУЛЬМИРА СЕРГАЗИНОВНА
Download

Founders

Accreditations

Employees

Affiliated companies

Premium

Director's involvement in other legal entities

Branches

Relations & mentions

Company networks

Premium

Similar companies

Media mentions

Company summary

Active legal entity ТОО "ЕВРОАЗИЯФАРМ" (BIN 100440017277), East Kazakhstan Region. Registered in 2010, 16 years on the market. Primary classifier activity: retail trade. Enterprise category: small enterprise, up to 5 employees. 17M ₸ in taxes was paid in 2025. In the public procurement register: 337 contracts as a supplier, total value 34.2M ₸; the latest contract was signed in 2024. Open registry checks show no risk indicators for «ЕВРОАЗИЯФАРМ». Latest registry change: change in headcount, November 1, 2026. Founders: 1. The registry names Какишева Камила Решатовна as director. Registry snapshot dated November 3, 2026.

Data sources and disclaimer

Sources: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is collected automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the fact. This is reference information and does not replace an official extract. Methodology: SafeDeal editorial policy.